Medical Education serves as a valuable platform for the pharmaceutical and biotech industries to inform key healthcare professionals about the latest developments in disease states and treatment protocols.
Still, growing regulatory scrutiny has led companies to re-examine their approach to conducting medical education. Critical elements for optimizing medical education capabilities include: structure and activities of the medical education function, effective medical education staffing levels, role of medical education group in important activities (including involvement with thought leaders and professional societies) and allocation of resources by region and program type.